Ligand validation:6SP9

SB4: 4-(4-FLUOROPHENYL)-1-(4-PIPERIDINYL)-5-(2-AMINO-4-PYRIMIDINYL)-IMIDAZOLE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6SP9_SB4_A_401	91%	60%	0.076	0.964	0.78	0.74	-	-	0	0	100%	1
6Y7X_SB4_A_401	94%	64%	0.075	0.973	0.83	0.56	1	-	0	0	100%	1
6SPL_SB4_A_401	93%	57%	0.068	0.964	0.84	0.8	1	-	0	0	100%	1
6SOV_SB4_A_401	91%	64%	0.08	0.967	0.79	0.6	1	-	0	0	100%	1
6Y7Z_SB4_A_402	91%	57%	0.077	0.963	0.81	0.85	-	1	1	0	100%	1
6Y7Y_SB4_A_401	88%	58%	0.094	0.968	0.85	0.78	1	-	0	0	100%	1
4LOO_SB4_A_401	83%	9%	0.098	0.958	1.48	2.89	3	13	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.